Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Net Margin: 2010-2024

Historic Net Margin for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to -104.58%.

  • China Pharma Holdings' Net Margin rose 1546.00% to -86.15% in Q3 2025 from the same period last year, while for Sep 2025 it was -78.72%, marking a year-over-year increase of 685.00%. This contributed to the annual value of -104.58% for FY2024, which is 6067.00% down from last year.
  • China Pharma Holdings' Net Margin amounted to -104.58% in FY2024, which was down 138.16% from -43.91% recorded in FY2023.
  • China Pharma Holdings' Net Margin's 5-year high stood at -26.38% during FY2020, with a 5-year trough of -104.58% in FY2024.
  • In the last 3 years, China Pharma Holdings' Net Margin had a median value of -49.02% in 2022 and averaged -65.84%.
  • In the last 5 years, China Pharma Holdings' Net Margin skyrocketed by 16,313bps in 2020 and then slumped by 6,067bps in 2024.
  • Over the past 5 years, China Pharma Holdings' Net Margin (Yearly) stood at -26.38% in 2020, then crashed by 888bps to -35.26% in 2021, then crashed by 1,377bps to -49.02% in 2022, then soared by 511bps to -43.91% in 2023, then slumped by 6,067bps to -104.58% in 2024.